Head to head for first-timers
CoreAge Rx vs RENN Health
CoreAge Rx and RENN Health both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxRENN Health
Rank #257 for first-timers · Grade C
Mama-Match
Best for: Someone comfortable starting a conversation on a floor price, who will ask in writing for the maintenance rate and the membership cost before signing up.
Visit RENN HealthThe verdict for a first step
CoreAge Rx edges out RENN Health on the Mama-Match Score, 94 to 44 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
RENN Health is still a genuine option — from $149 and $199, but both are floor figures: no ceiling, no dose ladder, and no price for the membership tiers it does name. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | RENN Health |
|---|---|---|
| Mama-Match Score | 94/100 · A | 44/100 · C |
| Overall rank | #1 | #257 |
| Semaglutide | $99/mo | From $149/mo (a floor) |
| Tirzepatide | $149/mo | $199/mo |
| Coverage | All 50 states | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
RENN Health
Rank #257 · Grade C
What we like
- The homepage and both drug pages now quote the same figures, having previously contradicted each other
- Tirzepatide at $199 is at the low end of what is charged for the dual agonist
- It delivers the medication directly, with NAD+ therapy from the same clinic
The caveats
- Both prices are “as low as” floors, with no ceiling or dose ladder published
- The memberships page names tiers and publishes no price for any of them
- The bundles' stack discounts are never quantified
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and RENN Health with the other providers we review for women.
Or browse the full comparison hub.